Search
Searching Content indexed under Intellectual Property by Eileen McMahon ordered by Published Date Descending.
Links to Result pages
 
1 2  
>>Next
 
Title
Country
Organisation
Author
Date
1
FCA Sends Differin Pricing Matter Back To PMPRB
The PMPRB is an administrative board established by the Patent Act with a mandate to protect Canadians from excessive drug pricing.
Canada
15 Aug 2019
2
Federal Court Of Appeal's Ruling On The Judicial Review Of PMPRB Decision On Differin
On June 28, the Federal Court of Appeal (FCA) affirmed the lower court's approach to patent review in determining whether the Patented Medicine Prices Review Board (PMPRB)
Canada
22 Jul 2019
3
The USMCA: Good News For Intellectual Property Rights Holders
Canada's current intellectual property laws, including the imminent amendments to the Trademarks Act and Industrial Designs Act, are largely compliant with the obligations imposed by the USMCA.
Canada
17 Oct 2018
4
Finalizing Patent Term Extension In Canada
The finalized Certificate of Supplementary Protection Regulations (CSP Regulations) were published in Canada Gazette, Part II on September 7 and will come into force on September 21.
Canada
21 Sep 2017
5
Canada Edges Toward Patent Term Extension
On July 15, the Government of Canada published its proposed Certificate of Supplementary Protection Regulations (Regulations)...
Canada
9 Aug 2017
6
Government Of Canada Successful In Eli Lilly's NAFTA Challenge On The Promise Of The Patent Doctrine
On March 16, 2017, an arbitral tribunal appointed pursuant to the NAFTA, released its final decision in favour of the Government of Canada regarding Eli Lilly's case against the "promise utility doctrine."
Canada
4 May 2017
7
Coming Soon: Pre-Consultation Draft Of Canadian Patent Rules
Public consultation for the long-awaited amendments to the Canadian Patent Rules is expected to begin this summer.
Canada
7 Apr 2017
8
Canada And CETA: Changes To Patent Term Restoration, PM(NOC) Decisions Appeals And Dual Litigation
On October 30, Canada signed the Comprehensive Economic and Trade Agreement (CETA) at the European Union-Canada Leaders' Summit.
Canada
1 Dec 2016
9
Canada Closes Door To Consumer Class Actions Based On Invalidated Pharma Patents
Following a landmark decision from the Supreme Court of Canada in 2012, the Federal Court of Appeal invalidated the Pfizer patent to the active ingredient in Viagra.
Canada
27 Jan 2016
10
Combination Drugs: Industry Canada To Amend The PM(NOC) Regulations
Industry Canada has announced that the Patent Medicines (Notice of Compliance) Regulations (PM(NOC) Regulations) will be amended...
Canada
17 Apr 2015
11
Federal Court Considers Patent Listing For Combination Drug Products
The Federal Court upheld two rulings of a prothonotary, both regarding listing of patents on the Patent Register under the Patented Medicines (Notice of Compliance) Regulations.
Canada
21 Oct 2014
12
Patent Law And Data Protection Under The Canada-European Union: Comprehensive Economic And Trade Agreement (CETA)
On September 26, 2014, the official text of the Canada-European Union: Comprehensive Economic and Trade Agreement (CETA) was published.
Canada
11 Oct 2014
13
Proposed Treatment of Confidential Business Information Under Vanessa’s Law (Bill C-17)
On June 16, 2014, amendments to Bill C-17, Protecting Canadians from Unsafe Drugs Act (the Bill), were announced.
Canada
11 Jul 2014
14
Data Protection: Sanofi Gains Standing In Hospira’s Objection To Application Of Data Protection
The Federal Court of Canada granted standing to Sanofi-Aventis Canada Inc. in a case involving a Sanofi product on the Register of Innovative Drugs.
Canada
9 Jun 2014
15
Look Before You Leap: Pre-Canadian Launch Regulatory Considerations For U.S. Companies
Deciding whether or not to launch a food, drug, medical device, dietary supplement or cosmetic product in Canada involves a number of considerations.
Canada
20 May 2014
16
The CADTH Releases Submission Guidelines For Biosimilars
The Canadian Agency for Drugs and Technologies in Health released Common Drug Review Procedure and Submission Guidelines for Subsequent Entry Biologics.
Canada
3 Apr 2014
17
IP Legislation Update
The Canadian government recently tabled a number of treaties involving intellectual property in the House of Commons and reintroduced Combating Counterfeit Products Act.
Canada
12 Mar 2014
18
Six Rules For Wooing Investors
Biotech companies must compete for funding against other biotech firms and start-ups in other sectors.
Canada
26 May 2011
19
Deadline for Compliance of Medical Device Software in Canada: February 1, 2011
The Medical Devices Bureau of Health Canada (the Bureau) expects that all Class I Medical Device software marketed in Canada will be compliant with the Medical Devices Regulations (the Regulations) by February 1, 2011, and all Class II Medical Device software will be compliant by September 1, 2011.
Canada
18 Jan 2011
20
Classify Patient Management Software in Canada
Health Canada has Clarified the approach taken by its Medical Devices Bureau to Classify Patient Management Software as Either A Class I Or A Class II Medical Device
Canada
21 Jun 2010
Links to Result pages
 
1 2  
>>Next